HAIN:NASDAQThe Hain Celestial Group, Inc. Analysis
Data as of 2026-09-26 - not real-time
$0.50
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The Hain Celestial Group, Inc. is priced at $0.4975, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 16.7%. Momentum indicators put RSI at 34.8 (approaching oversold) with MACD reading bearish. Price has been bracketed by support at $0.4800 and resistance at $0.7700.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 201.5% above where the shares trade now. Revenue is contracting at 27.6% on a -22.5% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 121.8%, a beta of 1.87 and a maximum drawdown of 69.8%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 201.5% above where the shares trade now. Revenue is contracting at 27.6% on a -22.5% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 121.8%, a beta of 1.87 and a maximum drawdown of 69.8%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Top Market Events
…/ Hain Celestial HAIN Q2 Earnings: What To Expect Hain Celestial / Shelf-Stable Food / Consumer Staples / All Stocks...Natural food company Hain Celestial NASDAQ:HAIN in Q2 CY2026, with sales falling 27.Earnings results often indicate what direction a company will take in the months ahead.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 0.79
- MACD momentum is negative
- 30-day price change of -16.7%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 0.79
- Analyst targets imply +201.5% versus the current price
- 30-day volatility of 121.8%
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -22.5%
- Analyst targets imply +201.5% versus the current price
- Negative return on equity of -96.8%
Key Metrics & Analysis
Financial Health
Revenue Growth-27.60%
Profit Margin-22.53%
P/E Ratio-248.7
ROE-96.83%
ROA0.86%
Debt/Equity393.72
P/B Ratio0.3
Op. Cash Flow$78.3M
Free Cash Flow$140.1M
Technical Analysis
TrendNeutral
RSI34.8
Support$0.48
Resistance$0.77
MA 20$0.63
MA 50$0.61
MA 200$0.79
MACDBearish
VolumeIncreasing
Fear & Greed Index94.88
Valuation
Fair Value$12.43
Target Price$1.50
Upside/Downside201.51%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.87
Volatility121.76%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.